| Approved on: | 2024-02-14 |
| Brief purpose of the study: | This study is about seeing whether hyperpolarized xenon Magnetic Resonance Imaging (MRI) can predict how a patient responds to treatment with biologics. |
| Brief summary of what participants will be asked to do: | Undergo MRI with inhaled xenon, before and after breathing in albuterol. Complete pulmonary function testing, answer questionnaires, and have some blood work. Three visits are required-one visit before beginning treatment, then two visits after beginning treatment at 4 weeks and 12 weeks. |
| Basic eligibility criteria: | Diagnosed with asthma, at clinical baseline, and about to start on biologic therapy. Ages 12 and older. |
| Study contact for more information: | Email: umhsradresearch@health.missouri.edu or call 573-884-5372 |
| IRB Number: | 2020641 MU |
